HIV-1 Group M Capsid Amino Acid Variability: Implications for Sequence Quality Control of Genotypic Resistance Testing.
Kaiming TaoSoo-Yon RheePhilip L TzouZachary A OsmanSergei L Kosakovsky PondSusan P HolmesRobert W ShaferPublished in: Viruses (2023)
Knowing the distribution of usual capsid mutations is essential for sequence quality control. Comparing capsid sequences from lenacapavir-treated and lenacapavir-naïve individuals will enable the identification of additional mutations potentially associated with lenacapavir therapy.